Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe hemophilia A

Informations projet

HemAcure

N° de convention de subvention: 667421

DOI 10.3030/667421

Projet clôturé

Date de signature de la CE 9 Decembre 2015

Date de début 1 Novembre 2015

Date de fin 31 Octobre 2018

Financé au titre de

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coût total € 5 564 395,00

Contribution de l’UE € 5 564 395,00

Coordonné par

UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT
Germany

Livrables

Documents, reports (2)

Exploitation activity (as above)
Individualized press release for every partner

Other (1)

Final dissemination activity on project results

Websites, patent fillings, videos etc. (1)

Launch of website, Twitter, Facebook, LinkedIn etc.

Publications

Other (1)

Combined ATMPs Containing Genetically Modified Cells

Auteurs: Patrick Bittorf, Martin Zierau, Ralf Sanzenbacher, Heike Walles, Joris Braspenning
Publié dans: Pharmazeutische Medizin, 2017, Page(s) 168-174
Éditeur: DeGePe GmbH

Thesis and dissertations (2)

"""Use of BOECs for therapeutic applications"""

Auteurs: Miguel Rodrigues
Publié dans: 2018
Éditeur: University of Wuerzburg

Genetically modified cells for treatment of heamophilia A

Auteurs: Patrick Bittorf
Publié dans: 2019
Éditeur: University Würuburg

Conference proceedings (4)

Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe haemophilia A

Auteurs: Chiara Borsotti, Simone Merlin, Cristina Olgasi, Thorsten Bergmann, Delfina M. Mazzuca, Alexandra Stolzing, Martin Zierau, Philip M. Toleikis, Joris Braspenning and Antonia Follenzi
Publié dans: Blood Transfusion, Numéro Vol.15, Supplement No. 3, September 2017, 2017, Page(s) s483, ISSN 1723-2007
Éditeur: Edizioni SIMTI

Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe haemophilia A

Auteurs: C Olgasi, S Merlin, C Borsotti, T Bergmann, D M Mazzucca, A Stolzing, M Zierau, P M Toleikis, J Braspenning, A Follenzi  
Publié dans: ESGCT abstract book 2018, Numéro 16th-19th October 2018, 2018
Éditeur: ESGCT

Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe haemophilia A (poster presentation at ESGCT congress, Berlin, 2017)

Auteurs: Cristina Olgasi, Simone Merlin, Thorsten Bergmann, Chiara Borsotti, Delfina M. Mazzuca, Alexandra Stolzing, Martin Zierau, Philip M. Toleikis, Joris Braspenning and Antonia Follenzi
Publié dans: Human Gene Therapy, Numéro Vol.28, No. 12, 1st December 2017, 2017, Page(s) pp A92, ISSN 1043-0342
Éditeur: Mary Ann Liebert

Advancing Tissue and Regenerative Engineering in UK Medicine (ATREUM) abstracts booklet

Auteurs: Harrison, Richard P., Adams, Christopher F.
Publié dans: 2017, ISBN 978-0-9955941-0-4
Éditeur: University Loughborough